Gastrointestinal Disorders in HIV

Global HIV/AIDS Medicine

Volumn , Issue , 2008, Pages 251-260

  Serlin, Michael H ^a,b   Dieterich, Douglas ^b  

^a NORTH GENERAL HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884440765     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2882-6.50027-7     Document Type: Chapter

References (47)

1. Connolly GM, Hawkins D, Harcourt-Webster JN, et al. Oesophageal symptoms, their causes, treatment and prognosis in patients with AIDS. Gut 1989, 30:1033-1039.
2. Zalar AE, Olmos MA, Piskorz EL, et al. Esophageal motility disorders in HIV patients. Dig Dis Sci 2003, 48:962-967.
3. Bach MC, Valenti AJ, Howell DA Odynophagia from aphthous ulcers of the pharynx and esophagus in AIDS. Ann Intern Med 1988, 109:338-339.
4. Kotler DP, Reka S, Orenstein JM, et al. Chronic idiopathic esophageal ulceration in AIDS: characterization and treatment with corticosteroids. J Clin Gastroenterol 1992, 15:284-290.
5. Monkemuller KE, Call SA, Lazenby AJ, et al. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol 2000, 95:457-462.
6. Wilcox CM, Alexander LN, Clark WS, et al. Fluconazole compared with endoscopy for human immunodeficiency virus- infected patients with esophageal symptoms. Gastroenterology 1996, 110:1803-1809.
7. Dolin R, Masur H, Saag MS AIDS therapy 2002, Churchill Livingstone, Edinburgh. 2nd edn.
8. Wilcox CM, Straub RF, Schwartz DA Prospective endoscopic characterization of cytomegalovirus esophagitis in patients with AIDS. Gastrointest Endosc 1994, 40:481.
9. Wilcox CM, Rodgers W, Lazenby A Prospective comparison of brush cytology, viral culture, and histology for the diagnosis of ulcerative esophagitis in AIDS. Clin Gastroenterol Hepatol 2004, 2:564-567.
10. Bini EJ, Micale PL, Weinshel EH Natural history of HIV-associated esophageal disease in the era of protease inhibitor therapy. Dig Dis Sci 2000, 45:1301-1307.
11. Wilcox CM, Straub RF, Clark WS Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulcer. Am J Gastroenterol 1995, 90:1938.
12. Wilcox CM, Straub RF, Alexander LN, et al. Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy. Am J Med 1996, 101:599-604.
13. Koletar SL, Russell JA, Fass RJ, et al. Comparison of oral fluconazole and clotrimazole troches as treatment of oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1990, 34:2267.
14. Pons V, Greenspan D, Lozada-Nur F Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Clin Infect Dis 1997, 24:1204-1207.
15. Barbaro G, Barbarini G, Calderon, et al. Fluconazole versus itraconazole for Candida esophagitis in AIDS. Gastroenterology 1996, 111:1169-1177.
16. Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS: a randomized trial. Ann Intern Med 1992, 117:655.
17. Villanueva A, Gotuzzo E, Arathoon EG, et al. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med 2002, 113:294-299.
18. Wilcox CM, Schwartz DA, Clark WS Esophageal ulceration in human immunodeficiency virus infection: causes, response to therapy, and long-term outcome. Ann Intern Med 1995, 123:143-149.
19. Goodgame RW, Genta RM, Estrada R, et al. Frequency of positive tests for cytomegalovirus in AIDS patients: endoscopic lesions compared with normal mucosa. Am J Gastroenterol 1993, 88:338.
20. Cheung TW, Teich SA Cytomegalovirus infection in patients with HIV infection. Mt Sinai J Med 1999, 66:113-124.
21. Laine L, Bonacini M, Sattler F, et al. Cytomegalovirus and Candida esophagitis in patients with AIDS. J Acquir Immune Defic Syndr 1992, 5:605-609.
22. Parente F, Bianchi Porro G Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. Ital Cytomegalovirus Study Group Am J Gastroenterol 1998, 93:317-322.
23. Dieterich DT, Poles MA, Dicker M, et al. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. Am J Gastroenterol 1993, 88:542-548.
24. McBane RD, Gross JB Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointest Endosc 1991, 37:600-603.
25. Verdonck LF, Cornelissen JJ, Smit J, et al. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT. Bone Marrow Transplant 1993, 11:177-179.
26. Wilcox CM, Schwartz DA A pilot study of oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection. Am J Med 1992, 93:131-134.
27. Jacobson JM, Spritzler J, Fox L, et al. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis 1999, 180:61-67.
28. Chiu HM, Wu MS, Hung CC Low prevalence of Helicobacter pylori but high prevalence of cytomegalovirus-associated peptic ulcer disease in AIDS patients: Comparative study of symptomatic subjects evaluated by endoscopy and CD4 counts. J Gastroenterol Hepatol 2004, 19:423-428.
29. Call SA, Heudebert G, Saag M, et al. The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm *. Am J Gastroenterol 2000, 95:3142-3146.
30. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002, 360:1375-1380.
31. Miao YM, Gazzard BG Management of protozoal diarrhoea in HIV disease. HIV Med 2000, 1:194-199.
32. Mitra AK, Hernandez CD, Hernandez CA, et al. Management of diarrhea in HIV-infected patients. Int J STD AIDS 2001, 12:630-639.
33. Meyer M Palliative care and AIDS: 2 - Gastrointestinal symptoms. Int J STD AIDS 1999, 10:495-507.
34. Thomas PD, Pollok RCG, Gazzard BG Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1999, 1:19-24.
35. Bini EJ, Cohen J Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea. Am J Gastroenterol 1999, 94:3553-3559.
36. Gray JR, Rabeneck L Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol 1989, 84:1521.
37. Chin DP, Hopewell PC, Yajko DM, et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis 1994, 169:289.
38. Bellomo AR, Perlman DC, Kaminsky DL, et al. Pneumocystis colitis in a patient with the acquired immunodeficiency syndrome. Am J Gastroenterol 1992, 87:759-761.
39. Hsu RB, Tsay YG, Chen RJ, et al. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003, 36:829-834.
40. Wheat LJ, Connoly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis, and treatment, and review of the literature. Medicine 1990, 69:361.
41. Sherman DS, Fish DN Management of protease inhibitor-associated diarrhea. Clin Infect Dis 2000, 30:908-914.
42. Guest JL, Ruffin C, Tschampa JM, et al. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Pharmacotherapy 2004, 24:727-735.
43. Sharpstone DR, Duggal A, Gazzard BG Inflammatory bowel disease in individuals seropositive for the human immunodeficiency virus. Eur J Gastroenterol Hepatol 1996, 8:575-578.
44. Gonzalez-Ruiz C, Heartfield W, Briggs B, et al. Anorectal pathology in HIV/AIDS-infected patients has not been impacted by highly active antiretroviral therapy. Dis Colon Rectum 2004, 47:1483-1486.
45. Rabkin CS, Yellin F Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994, 86:1711-1716.
46. Friedlander MA, Stier E, Lin O Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic, and histologic correlation. Cancer 2004, 102:19-26.
47. Klausner JD, Kohn R, Kent C Etiology of clinical proctitis among men who have sex with other men. Clin Infect Dis 2004, 38:300-302.